Neutropenia as a prognostic factor in metastatic colorectal cancer patients undergoing chemotherapy with first-line FOLFOX

被引：0
|
作者：
Shitara, K. [1 ]
Matsuo, K. [1 ]
Takahari, D. [1 ]
Yokota, T. [1 ]
Ura, T. [1 ]
Muro, K. [1 ]
机构：
[1] Aichi Canc Ctr, Nagoya, Aichi 464, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4115
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Addition of bevacizumab to first-line FOLFOX4 and overall survival in patients with metastatic colorectal cancer.
    Suenaga, Mitsukuni
    Matsusaka, Satoshi
    Mizunuma, Nobuyuki
    Shinozaki, Eiji
    Ogura, Mariko
    Ozaka, Masato
    Takagi, Koichi
    Yamaguchi, Toshiharu
    Hatake, Kiyohiko
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [42] Examining Metabolomics as a Prognostic Marker in Metastatic Non-Small Cell Lung Cancer Patients Undergoing First-Line Chemotherapy
    Hao, D.
    Sengupta, A.
    Ding, K.
    Leighl, N.
    Shepherd, F.
    Seymour, L.
    Weljie, A.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2089 - S2089
  • [43] First-line treatment options for patients with metastatic colorectal cancer
    Richard L Schilsky
    Nature Clinical Practice Oncology, 2004, 1 : 70 - 71
  • [44] First-line treatment options for patients with metastatic colorectal cancer
    Schilsky, Richard L.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2004, 1 (02): : 70 - 71
  • [45] Bevacizumab in combination with first-line chemotherapy in patients with metastatic colorectal cancer: a meta-analysis
    Hu, W.
    Xu, W. -S.
    Liao, X. -F.
    He, H. -J.
    MINERVA CHIRURGICA, 2015, 70 (06) : 451 - 458
  • [46] Hope, optimism, and survival in a randomized trial of first-line chemotherapy for patients with metastatic colorectal cancer
    Schofield, P.
    Stockler, M.
    Zannino, D.
    Wong, N.
    Ransom, D.
    Moylan, E.
    Simes, R. J.
    Price, T. J.
    Tebbutt, N. C.
    Jefford, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [47] Prognostic Factors in First-Line Chemotherapy Treated Metastatic Gastric Cancer Patients: A Retrospective Study
    Inal, Ali
    Kaplan, M. Ali
    Kucukoner, Mehmet
    Urakci, Zuhat
    Guven, Mehmet
    Nas, Necip
    Yunce, Muharrem
    Isikdogan, Abdurrahman
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (08) : 3869 - 3872
  • [48] Handy prognostic model in patients with oxaliplatin-based or irinotecan-based first-line chemotherapy for metastatic colorectal cancer
    Chibaudel, B.
    Tournigand, C.
    Bonnetain, F.
    Andre, T.
    Lledo, G.
    Maindrault-Goebel, F.
    Larsen, A. K.
    Louvet, C.
    de Gramont, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [49] Pharmacoeconomic analysis of XELOX versus FOLFOX for metastatic colorectal cancer first-line treatment in Taiwan
    Chen, H. -H.
    Chang, C. -S.
    Chen, L. -T.
    Chen, W. T. -L.
    Hsu, T. -C.
    Wang, J. -Y.
    ANNALS OF ONCOLOGY, 2015, 26 : 54 - 54
  • [50] Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer
    Bai, Long
    Wang, Feng
    Li, Zhe-zhen
    Ren, Chao
    Zhang, Dong-sheng
    Zhao, Qi
    Lu, Yun-xin
    Wang, De-shen
    Ju, Huai-qiang
    Qiu, Miao-zhen
    Wang, Zhi-qiang
    Wang, Feng-hua
    Xu, Rui-hua
    MEDICINE, 2016, 95 (51) : e4531
12345